Baird raised the firm’s price target on Bright Horizons (BFAM) to $140 from $131 and keeps a Neutral rating on the shares. The firm said they reportedmixed results but the upside was driven by continued excellent Back-Up Care. However, Full Service revenue versus same-center enrollment growth slowing, while 2024 Full Service revenue guidance narrowed to the lower half of the prior range.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFAM: